Heated chemo during surgery for advanced stomach cancer
Part of Cancer, Digestive system clinical trials.
This trial tests whether adding heated chemotherapy to the belly right after surgery can help people with stomach cancer live longer. It is done during the same operation, aiming to kill any remaining cancer cells.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have been diagnosed with stomach cancer that has grown into the muscle layer or further, but has not spread to distant organs.
- You are healthy enough to have a major surgery to remove the cancer and nearby lymph nodes (D2 dissection).
- You have not had chemotherapy, radiation, or immunotherapy for this cancer yet.
- You have not had another cancer in the past 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares standard laparoscopic surgery for stomach cancer versus the same surgery plus HIPEC, which is heated chemotherapy placed in the abdomen during the operation. It aims to see if adding the heated chemotherapy improves outcomes for people with higher-stage stomach cancer.
This trial tests combining standard chemotherapy and immunotherapy (tirelizumab) with heated chemotherapy given directly into the belly. It aims to treat stomach cancer that has spread to the abdominal lining, and may help shrink or control the cancer.
This trial tests a new way to give chemotherapy directly into the abdomen during surgery for stomach cancer that has a high risk of coming back. It may help reduce the chance of the cancer returning.
This trial tests a combination of chemotherapy drugs given before surgery for locally advanced stomach or gastroesophageal junction cancer. It aims to see if this approach helps shrink the tumor and improve outcomes.
This trial tests giving chemotherapy through a vein and directly into the belly before surgery for advanced stomach cancer. The goal is to shrink the cancer and see if this approach improves outcomes.
This trial compares two types of chemotherapy with or without an immunotherapy drug (tislelizumab) for advanced stomach or gastroesophageal junction cancer. It aims to see which combination works better and has fewer side effects.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.